Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients
- PMID: 38922908
- DOI: 10.1111/vox.13700
Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients
Abstract
Background and objectives: There is no consensus on a universally accepted threshold to categorize a patient as multitransfused. In 2019, Colombia established the definition of a multitransfused patient as someone who has received six or more blood components, irrespective of the time frame. This study aims to delineate the characteristics, adverse transfusion reactions (ATRs, definitions according to the International Society of Blood Transfusion [ISBT]) and survival rates in this population.
Materials and methods: We performed an analysis from the data of all institutions engaged in blood component transfusions at the national level who notified events to the National Information System of Haemovigilance (SIHEVI-INS), from January 2018 to December 2022. The selection criteria focused on individuals who not only exhibited ATRs but also received six or more blood components.
Results: Among the 1,784,428 patients who received 6,637,271 blood components, an average of 3.7 components per patient was noted. Concurrently, 8378 ATRs were reported (12.6 ATRs/10,000 transfused components). Within this cohort, 691 patients met the criteria for multitransfusion. Predominantly women (51.8%), these individuals received between 6 and 14 blood components. Out of the 691 multitransfused individuals who experienced ATR, 541 had an allergic reaction. Conversely, out of the 6479 non-multitransfused individuals who experienced ATR, 3835 had an allergic reaction (odds ratio: 2.49, 95% confidence interval: 2.06-3.0). Notably, 271 multitransfused individuals (39.2%) were documented as deceased, with 76% succumbing within 12 months of encountering their most recent ATR.
Conclusion: Multitransfused individuals in Colombia, being a high-risk group, exhibit a heightened susceptibility to allergic reactions, surpassing the frequency observed in other transfusion populations. This underscores the necessity for tailored medical care specific to this group.
Keywords: adverse transfusion reaction; blood components; blood transfusion; haemovigilance.
© 2024 International Society of Blood Transfusion.
Similar articles
-
Pediatric blood transfusions in Colombia: Dissecting adverse reaction trends and age dynamics.Transfusion. 2025 Jan;65(1):100-109. doi: 10.1111/trf.18074. Epub 2024 Nov 24. Transfusion. 2025. PMID: 39580794
-
Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020.Vox Sang. 2022 Aug;117(8):1027-1034. doi: 10.1111/vox.13291. Epub 2022 May 13. Vox Sang. 2022. PMID: 35560059
-
A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.Vox Sang. 2015 Apr;108(3):243-50. doi: 10.1111/vox.12208. Epub 2014 Dec 23. Vox Sang. 2015. PMID: 25536173
-
International haemovigilance: what have we learned and what do we need to do next?Transfus Med. 2019 Aug;29(4):221-230. doi: 10.1111/tme.12582. Epub 2019 Feb 6. Transfus Med. 2019. PMID: 30729612 Review.
-
Preventing adverse reactions in pediatric transfusions using washed platelet concentrate.Pediatr Int. 2021 Apr;63(4):391-403. doi: 10.1111/ped.14572. Epub 2021 Mar 27. Pediatr Int. 2021. PMID: 33290634 Review.
References
REFERENCES
-
- De Paula EV, Goncales NS, Xueref S, Addas‐Carvalho M, Gilli SC, Angerami RN, et al. Prevalence of transfusion‐transmitted Chagas disease among multitransfused patients in Brazil. BMC Infect Dis. 2008;8:5.
-
- Cruz RDO, Mota MA, Conti FM, d'Almeida PRA, Kutner JM, Aravechia MG, et al. Prevalence of erythrocyte alloimmunization in polytransfused patients. Einstein. 2011;9:173–178.
-
- Bajpai M, Gupta S, Jain P. Alloimmunization in multitransfused liver disease patients: impact of underlying disease. Asian J Transfus Sci. 2016;10:136–139.
-
- Salama KM, Selim OE‐S. Hepatitis G virus infection in multitransfused Egyptian children. Pediatr Hematol Oncol. 2009;26:232–239.
-
- Sinha M, Raghuwanshi B, Mishra B. Menace of hepatitis C virus among multitransfused thalassemia patients in Balasore district of Odisha state in India. J Family Med Prim Care. 2019;8:2850.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous